K. Jasas

Non-small cell lung cancer, locally advanced

P. Lambin, S. Kozlov, I. Petersen, 2012 .

Small cell lung cancer presenting with paraneoplastic limbic encephalitis

M. Millward, A. Nowak, D. Blacker, 2011, Asia-Pacific journal of clinical oncology.

Evaluation of a Clinic-Based Exercise Program in Patients with Pancreatic Cancer Undergoing Nonsurgical Treatment

N. Hart, F. Singh, D. Galvão, 2022, Medicine and science in sports and exercise.

Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCIC CTG IND-148.

E. Eisenhauer, A. Oza, J. Dancey, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer.

P. Ellis, Colum J Smith, C. Butts, 2010, Clinical lung cancer.

Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial

R. Newton, D. Galvão, N. Spry, 2021, BMJ open gastroenterology.

Exercise as medicine in the management of pancreatic cancer: a case study.

R. Newton, D. Galvão, N. Spry, 2014, Medicine and science in sports and exercise.

185 Early results of a phase II study of oral topotecan and intravenous cisplatin in epithelial ovarian cancer recurring more than 6 months following initial platinum therapy

A. Oza, G. Stuart, M. Trudeau, 2003 .

Patterns of care for stage III non–small cell lung cancer in Australia

S. Kao, B. Chan, B. Hughes, 2019, Asia-Pacific journal of clinical oncology.

A multi-centre, open-label study to assess the safety of Stimuvax (BLP25 liposome vaccine or L-BLP25) in non-small cell lung cancer (NSCLC) patients (pts) with unresectable stage III disease

P. Ellis, Colum J Smith, C. Butts, 2007 .